News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

USA Cycling Awarded the 2025 INFORMS Edelman Award for Data-Driven Olympic Gold Strategy
News Release

BALTIMORE, MD, April 7, 2025 – INFORMS, the world’s largest association for professionals and students in operations research (O.R.), AI, analytics and data science, announced it has awarded USA Cycling its 2025 Franz Edelman Award for Achievement in Advanced Analytics, Operations Research and Management Science, for its use of operations research (O.R.) and analytics in elite sports performance. With Project 4:05, USA Cycling transformed race strategy and athlete preparation, enabling the Women’s Team Pursuit to win gold at the 2024 Paris Olympics.

Read More
Trump Vows to Veto Bill Blocking Tariffs as Markets Reel
Media Coverage

A bipartisan push in Congress would return the power to impose tariffs to the legislature.

Read More
The Hidden Threat in America’s Defense: Our Energy Grid
Media Coverage

The threat of a terrorist attack on America’s energy grid is growing, with attempts being reported at increasing rates. If it’s not terrorism, it could be adversarial nation-states. This all increases the likelihood that a significant attack on the grid could succeed, leaving large swaths of the U.S. in the dark.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

INFORMS in the News

What are you looking for?

Type of Content
Topic
Can the Digital Advertising Market Achieve Privacy without Regulation?

Can the Digital Advertising Market Achieve Privacy without Regulation?

News Release, March 8, 2021

CATONSVILLE, MD, March 8, 2021 – It’s a common assumption among marketers that if you can customize any form of marketing, particularly mobile advertising, you’ll get better results. With this in mind, mobile marketing relies significantly on user tracking data as a cornerstone advertising strategy.

Backlash Against Johnson & Johnson's COVID-19 Vaccine is Real and Risky - Here's How to Make Its Rollout A Success

Backlash Against Johnson & Johnson's COVID-19 Vaccine is Real and Risky - Here's How to Make Its Rollout A Success

The Conversation, March 5, 2021

More than 50 million Americans have received at least one dose of either the Pfizer or Moderna COVID-19 vaccine. So far, Americans have been largely brand-agnostic, but that’s about to change as a new vaccine rolls out. The Johnson & Johnson vaccine has been hailed as a game changer. It requires only a single dose rather than two doses spaced weeks apart, and it does not need freezer storage, making it a natural fit for hard-to-reach rural areas and underserved communities with limited access to health care and storage facilities. But while many people are excited about the prospects of only one shot, the new vaccine is also getting backlash. Part of that is coming from lack of clarity about the vaccines’ efficacy numbers, and part of it is more nuanced. 

Backlash Against Johnson & Johnson's COVID-19 Vaccine is Real and Risky - Here's How to Make Its Rollout A Success

Backlash Against Johnson & Johnson's COVID-19 Vaccine is Real and Risky - Here's How to Make Its Rollout A Success

Times Union, March 5, 2021

More than 50 million Americans have received at least one dose of either the Pfizer or Moderna COVID-19 vaccine. So far, Americans have been largely brand-agnostic, but that’s about to change as a new vaccine rolls out. The Johnson & Johnson vaccine has been hailed as a game changer. It requires only a single dose rather than two doses spaced weeks apart, and it does not need freezer storage, making it a natural fit for hard-to-reach rural areas and underserved communities with limited access to health care and storage facilities. But while many people are excited about the prospects of only one shot, the new vaccine is also getting backlash. Part of that is coming from lack of clarity about the vaccines’ efficacy numbers, and part of it is more nuanced.

Backlash Against Johnson & Johnson's COVID-19 Vaccine is Real and Risky - Here's How to Make Its Rollout A Success

Backlash Against Johnson & Johnson's COVID-19 Vaccine is Real and Risky - Here's How to Make Its Rollout A Success

My Journal Courier, March 5, 2021

More than 50 million Americans have received at least one dose of either the Pfizer or Moderna COVID-19 vaccine. So far, Americans have been largely brand-agnostic, but that’s about to change as a new vaccine rolls out. The Johnson & Johnson vaccine has been hailed as a game changer. It requires only a single dose rather than two doses spaced weeks apart, and it does not need freezer storage, making it a natural fit for hard-to-reach rural areas and underserved communities with limited access to health care and storage facilities. But while many people are excited about the prospects of only one shot, the new vaccine is also getting backlash. Part of that is coming from lack of clarity about the vaccines’ efficacy numbers, and part of it is more nuanced.

The Secret Behind North Dakota’s Speedy Vaccine Rollout

The Secret Behind North Dakota’s Speedy Vaccine Rollout

Wired, March 4, 2021

The pharmacy in Hankinson, North Dakota, a town of about 900 people at the state’s extreme southeastern tip, has been in operation since 1897. The town was a decade old by then and had quickly swelled with settlers enticed by ads for good farmland along the railroad. A pharmacy was one of those signs of a town’s arrival; a knowledgeable druggist was essential. This remained true through the years, even though it turned out that the region’s population had already peaked and was slowly dwindling, as it still is. The earliest owners of Hankinson Drug had kept a stock of jewelry as well as pharmaceuticals, and both traditions remain alive with the current proprietors. In recent years, their pharmacy has been the only one in the county outside Wahpeton, a bigger town 30 minutes away on the Minnesota border.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine